State Street’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Sell
600,181
-36,853
-6% -$690K ﹤0.01% 2528
2025
Q1
$11.5M Buy
637,034
+256,519
+67% +$4.61M ﹤0.01% 2446
2024
Q4
$6.4M Buy
380,515
+12,720
+3% +$214K ﹤0.01% 2855
2024
Q3
$5.95M Buy
367,795
+2,552
+0.7% +$41.3K ﹤0.01% 2881
2024
Q2
$3M Sell
365,243
-8,237
-2% -$67.7K ﹤0.01% 3146
2024
Q1
$5.53M Buy
373,480
+15,472
+4% +$229K ﹤0.01% 2885
2023
Q4
$5.19M Buy
358,008
+7,639
+2% +$111K ﹤0.01% 2929
2023
Q3
$3.78M Sell
350,369
-2,053
-0.6% -$22.2K ﹤0.01% 3060
2023
Q2
$4.55M Buy
352,422
+7,806
+2% +$101K ﹤0.01% 3038
2023
Q1
$4.55M Buy
344,616
+7,125
+2% +$94.1K ﹤0.01% 3033
2022
Q4
$5.06M Sell
337,491
-50,316
-13% -$755K ﹤0.01% 3039
2022
Q3
$4.58M Sell
387,807
-2,006,750
-84% -$23.7M ﹤0.01% 3104
2022
Q2
$27.1M Buy
2,394,557
+1,642,136
+218% +$18.6M ﹤0.01% 2033
2022
Q1
$22.5M Sell
752,421
-104,160
-12% -$3.11M ﹤0.01% 2315
2021
Q4
$22.7M Sell
856,581
-13,263
-2% -$351K ﹤0.01% 2392
2021
Q3
$31.6M Sell
869,844
-199,348
-19% -$7.24M ﹤0.01% 2143
2021
Q2
$46.4M Sell
1,069,192
-182,481
-15% -$7.92M ﹤0.01% 1902
2021
Q1
$42.8M Buy
1,251,673
+315,423
+34% +$10.8M ﹤0.01% 1862
2020
Q4
$32.8M Sell
936,250
-74,385
-7% -$2.6M ﹤0.01% 1921
2020
Q3
$24.3M Buy
1,010,635
+654,265
+184% +$15.7M ﹤0.01% 1915
2020
Q2
$6.52M Buy
356,370
+1,406
+0.4% +$25.7K ﹤0.01% 2632
2020
Q1
$5.54M Sell
354,964
-12,694
-3% -$198K ﹤0.01% 2574
2019
Q4
$7.87M Buy
367,658
+27,194
+8% +$582K ﹤0.01% 2638
2019
Q3
$6.37M Sell
340,464
-338,381
-50% -$6.33M ﹤0.01% 2665
2019
Q2
$17.7M Sell
678,845
-114,822
-14% -$3M ﹤0.01% 2195
2019
Q1
$20.4M Buy
793,667
+33,467
+4% +$860K ﹤0.01% 2028
2018
Q4
$17.5M Buy
760,200
+39,751
+6% +$914K ﹤0.01% 2083
2018
Q3
$23.1M Sell
720,449
-79,078
-10% -$2.54M ﹤0.01% 2080
2018
Q2
$22.6M Buy
799,527
+299,686
+60% +$8.48M ﹤0.01% 2059
2018
Q1
$17.7M Buy
499,841
+100,985
+25% +$3.58M ﹤0.01% 2141
2017
Q4
$15.5M Buy
398,856
+173,563
+77% +$6.73M ﹤0.01% 2222
2017
Q3
$5.72M Buy
225,293
+6,393
+3% +$162K ﹤0.01% 2737
2017
Q2
$5.97M Buy
218,900
+9,064
+4% +$247K ﹤0.01% 2653
2017
Q1
$6.95M Buy
209,836
+38,599
+23% +$1.28M ﹤0.01% 2544
2016
Q4
$4.07M Buy
171,237
+11,280
+7% +$268K ﹤0.01% 2798
2016
Q3
$5.87M Buy
159,957
+1,067
+0.7% +$39.1K ﹤0.01% 2469
2016
Q2
$3.54M Buy
158,890
+10,981
+7% +$245K ﹤0.01% 2807
2016
Q1
$3.08M Buy
147,909
+3,874
+3% +$80.5K ﹤0.01% 2799
2015
Q4
$4.36M Buy
144,035
+306
+0.2% +$9.26K ﹤0.01% 2607
2015
Q3
$3.55M Sell
143,729
-2,209
-2% -$54.6K ﹤0.01% 2693
2015
Q2
$4.69M Sell
145,938
-1,568
-1% -$50.4K ﹤0.01% 2654
2015
Q1
$5.27M Buy
147,506
+3,694
+3% +$132K ﹤0.01% 2541
2014
Q4
$3.27M Sell
143,812
-5,845
-4% -$133K ﹤0.01% 2795
2014
Q3
$2.9M Buy
149,657
+4,858
+3% +$94.1K ﹤0.01% 2822
2014
Q2
$5.26M Sell
144,799
-5,239
-3% -$190K ﹤0.01% 2567
2014
Q1
$5.82M Buy
150,038
+3,326
+2% +$129K ﹤0.01% 2496
2013
Q4
$4.18M Buy
146,712
+1,487
+1% +$42.4K ﹤0.01% 2678
2013
Q3
$5.2M Sell
145,225
-244,843
-63% -$8.77M ﹤0.01% 2510
2013
Q2
$13M Buy
+390,068
New +$13M ﹤0.01% 1899